Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Amgen Inc.

Amgen Inc. (AMGN) Stock Overview

Explore Amgen Inc.’s financial performance, market position, analyst ratings, and future outlook.

AMGN●NASDAQ
HealthcareDrug Manufacturers - General
$417.20
$12.35(3.05%)
U.S. Market opens in 0h 49m

Amgen Inc. (AMGN)

Meyka AI Score

Z

Key Financials

Market Cap221.8B
P/E Ratio25.53
EPS (TTM)$22.37
ROE0.89%
Fundamental Analysis

AI Price Forecasts

1 Month$378.02
3 Months$386.75
1 Year Target$349.96

AMGN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Amgen Inc. (NASDAQ: AMGN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Amgen Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AMGN on the NASDAQ shows an RSI of 73.97, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $349.96 for the NASDAQ listing.

Key metrics behind Amgen Inc.'s NASDAQ-traded stock include a P/E ratio of 25.53 and a market capitalization of 221.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AMGN on the NASDAQ.

Price Performance (NASDAQ: AMGN)

1-Day Change
1.52%
5-Day Change
6.06%
1-Month Change
14.81%
3-Month Change
25.78%
6-Month Change
14.41%
Year-to-Date (YTD) Change
27.46%
1-Year Change
46.34%
3-Year Change
59.20%
5-Year Change
83.01%
All-Time (Max) Change
121267.27%

Contact Information

https://www.amgen.com
805 447 1000
One Amgen Center Drive, Thousand Oaks, CA, 91320-1799

Company Facts

315,000 Employees
IPO DateJun 17, 1983
CountryUS
Actively Trading

Frequently Asked Questions